{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:43:27Z","timestamp":1791434607792,"version":"4.3.3"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Italian Ministry of Health, Section for the Monitoring and Control of Doping and the Protection of Health in Sporting Activities","award":["J52I14001600005"],"award-info":[{"award-number":["J52I14001600005"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.jchromb.2016.12.038","type":"journal-article","created":{"date-parts":[[2016,12,30]],"date-time":"2016-12-30T14:20:32Z","timestamp":1483107632000},"page":"77-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"special_numbering":"C","title":["Dried haematic microsamples and LC\u2013MS\/MS for the analysis of natural and synthetic cannabinoids"],"prefix":"10.1016","volume":"1044-1045","author":[{"given":"Michele","family":"Protti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Rudge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Eliseo","family":"Sberna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto","family":"Gerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mercolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2016.12.038_bib0005","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/sj.ijo.0803272","article-title":"The pharmacology of cannabinoid receptors and their ligands: an overview","volume":"30","author":"Pertwee","year":"2006","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0010","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2174\/0929867054020864","article-title":"Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes","volume":"12","author":"Huffman","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s40429-014-0014-y","article-title":"Synthetic cannabinoids: pharmacology, behavioral effects, and abuse potential","volume":"1","author":"Tai","year":"2014","journal-title":"Curr. Addict. Rep."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0020","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) New psychoactive substances in Europe \u2212 An update from the EU Early Warning System. http:\/\/www.emcdda.europa.eu\/publications\/2015\/new-psychoactive-substances, 2015 (accessed 29.07.2016)."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0025","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2174\/0929867306666220401125055","article-title":"Cannabimimetic indoles pyrroles and indenes","volume":"6","author":"Huffman","year":"1999","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0030","unstructured":"United Nations Office on Drugs and Crime (UNODC) Synthetic cannabinoids in herbal products. https:\/\/www.unodc.org\/documents\/scientific\/Synthetic_Cannabinoids.pdf, (accessed 29.07.2016)."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0035","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.4155\/bio.14.156","article-title":"Spot them in the spot: analysis of abused substances using dried blood spots","volume":"6","author":"Sadones","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2016.12.038_bib0040","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/FTD.0b013e31819e91ce","article-title":"Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls","volume":"31","author":"Edelbroek","year":"2009","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0045","doi-asserted-by":"crossref","first-page":"7242","DOI":"10.1016\/j.chroma.2010.09.037","article-title":"Analysis of cocaine and two metabolites in dried blood spots by liquid chromatography with fluorescence detection: a novel test for cocaine and alcohol intake","volume":"1217","author":"Mercolini","year":"2010","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2016.12.038_bib0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.chroma.2012.11.030","article-title":"Dried blood spots: liquid chromatography-mass spectrometry analysis of \u03949-tetrahydrocannabinol and its main metabolites","volume":"1271","author":"Mercolini","year":"2013","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2016.12.038_bib0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4155\/bio.13.327","article-title":"Bioanalysis zone: DBS survey results","volume":"6","author":"Denniff","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2016.12.038_bib0060","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.4155\/bio.14.3","article-title":"Dried blood spot testing: a novel approach for the therapeutic drug monitoring of ziprasidone-treated patients","volume":"6","author":"Mercolini","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2016.12.038_bib0065","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.4155\/bio.15.123","article-title":"Current advances in biosampling for therapeutic drug monitoring of psychiatric CNS drugs","volume":"15","author":"Mercolini","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2016.12.038_bib0070","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jpba.2016.06.046","article-title":"Biosampling strategies for emerging drugs of abuse: towards the future of toxicological and forensic analysis","volume":"130","author":"Mercolini","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0075","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4155\/bio.14.310","article-title":"A device for dried blood microsampling in quantitative bioanalysis: overcoming the issues associated blood hematocrit","volume":"7","author":"Spooner","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2016.12.038_bib0080","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.1021\/ac5022562","article-title":"Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis","volume":"86","author":"Denniff","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0085","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jpba.2016.02.015","article-title":"LC\u2013MS\/MS and volumetric absorptive microsampling for quantitative bioanalysis of cathinone analogues in dried urine, plasma and oral fluid samples","volume":"123","author":"Mercolini","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0090","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jms.1877","article-title":"Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples","volume":"46","author":"Dresen","year":"2011","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0095","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.jchromb.2010.03.016","article-title":"Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl) methanone (JWH-018) in human serum by liquid chromatography-tandem mass spectrometry","volume":"878","author":"Teske","year":"2010","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2016.12.038_bib0100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jat\/bks013","article-title":"Detection of JWH-018 and JWH-073 by UPLC\u2013MS-MS in postmortem whole blood casework","volume":"36","author":"Shanks","year":"2012","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0105","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/jat\/bks048","article-title":"Detection and quantification of new designer drugs in human blood: part 1 \u2212 synthetic cannabinoids","volume":"36","author":"Ammann","year":"2012","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0110","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.forsciint.2014.12.029","article-title":"Validation of JWH-018 and its metabolites in blood and urine by UPLC-MS\/MS: Monitoring in forensic cases","volume":"248","author":"Erol \u00d6zt\u00fcrk","year":"2015","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0115","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1007\/s00216-015-8605-6","article-title":"Simultaneous LC-MS\/MS determination of JWH-210 RCS-4, \u0394(9)-tetrahydrocannabinol, and their main metabolites in pig and human serum, whole blood, and urine for comparing pharmacokinetic data","volume":"407","author":"Schaefer","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0120","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jchromb.2011.03.034","article-title":"Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures","volume":"879","author":"Grigoryev","year":"2011","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2016.12.038_bib0125","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00216-011-4931-5","article-title":"Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC\u2013MS\/MS-based drug testing","volume":"401","author":"Beuck","year":"2011","journal-title":"Anal. Bional. Chem."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.forsciint.2010.04.003","article-title":"Detection of JWH-018 metabolites in smoking mixture post-administration urine","volume":"200","author":"Sobolevsky","year":"2010","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0135","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/jat\/bku178","article-title":"A sensitive GC-EIMS method for simultaneous detection and quantification of JWH-018 and JWH-073 carboxylic acid and hydroxy metabolites in urine","volume":"39","author":"Paul","year":"2015","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0140","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1021\/ac2005636","article-title":"Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine","volume":"83","author":"Moran","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0145","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jchromb.2012.04.002","article-title":"LC\u2013MS\/MS method for the quantitation of metabolites of eight commonly-used synthetic cannabinoids in human urine?an Australian perspective","volume":"897","author":"de Jager","year":"2012","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2016.12.038_bib0150","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/dta.1429","article-title":"Analysis of 30 synthetic cannabinoids in oral fluid using liquid chromatography-electrospray ionization tandem mass spectrometry","volume":"5","author":"Kneisel","year":"2013","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0155","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.4155\/bio.13.182","article-title":"Screening of synthetic cannabinoids in preserved oral fluid by UPLC\u2013MS\/MS","volume":"5","author":"Oiestad","year":"2013","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2016.12.038_bib0160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.chroma.2013.04.035","article-title":"Quantification of selected synthetic cannabinoids and \u03949-tetrahydrocannabinol in oral fluid by liquid chromatography-tandem mass spectrometry","volume":"1295","author":"de Castro","year":"2013","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2016.12.038_bib0165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.chroma.2012.07.098","article-title":"Ultra high performance liquid chromatography-electrospray ionization-tandem mass spectrometry screening method for direct analysis of designer drugs, spice and stimulants in oral fluid","volume":"1258","author":"Strano-Rossi","year":"2012","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2016.12.038_bib0170","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/anatox\/35.7.424","article-title":"Synthetic cannabinoids in oral fluid","volume":"35","author":"Coulter","year":"2011","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0175","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jchromb.2012.07.002","article-title":"Determination of 22 synthetic cannabinoids in human hair by liquid chromatography-tandem mass, spectrometry","volume":"903","author":"Hutter","year":"2012","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2016.12.038_bib0180","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jpba.2014.09.013","article-title":"Simultaneous determination of five naphthoylindole-based synthetic cannabinoids and metabolites and their deposition in human and rat hair","volume":"102","author":"Kim","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0185","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jpba.2015.05.022","article-title":"Determination of XLR-11 and its metabolites in hair by liquid chromatography-tandem mass spectrometry","volume":"114","author":"Park","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0190","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/dta.342","article-title":"Dried blood spots (DBS) for doping control analysis","volume":"3","author":"Thomas","year":"2011","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0195","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.4155\/bio.14.151","article-title":"Current strategies for coping with the hematocrit problem in dried blood spot analysis","volume":"6","author":"De Kesel","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2016.12.038_bib0200","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1373\/clinchem.2005.056838","article-title":"Estimating the time of last cannabis use from plasma delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol concentrations","volume":"51","author":"Huestis","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0205","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1373\/clinchem.2008.114405","article-title":"Intra- and intersubject whole blood\/plasma cannabinoid ratios determined by 2-dimensional, electron impact GC\u2013MS with cryofocusing","volume":"55","author":"Schwilke","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jchromb.2016.12.038_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2325-9841.1000106","article-title":"Stability study of fifteen synthetic cannabinoids of aminoalkylindole type in whole blood: stored in Vacutainer\u00ae evacuated glass tubes","volume":"2","author":"Karinen","year":"2013","journal-title":"J. Forensic Toxicol. Pharmacol."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023216306171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023216306171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T05:19:52Z","timestamp":1658294392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023216306171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":42,"alternative-id":["S1570023216306171"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2016.12.038","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dried haematic microsamples and LC\u2013MS\/MS for the analysis of natural and synthetic cannabinoids","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2016.12.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}